Climb Bio (CLYM) Non Operating Income (2024 - 2026)
Climb Bio's (CLYM) quarterly Non Operating Income came in at $1.5 million in Q1 2026, down 33.44% YoY from $2.2 million in Q1 2025, and down 25.7% on a QoQ basis from $2.0 million in Q3 2025.
Climb Bio (CLYM) Non Operating Income (2024 - 2026) Analysis & Trends
Climb Bio (CLYM) has 3 years of Non Operating Income data on file, last reported at $1.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Climb Bio | 1.24 Bn | 1.24 Bn | - | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 1.48 Mn |